5 completed, 2 active not recruiting, 1 recruiting. 2 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Merz Therapeutics GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-world Patient Experiences With Inbrija® Levodopa inhalation powder - Parkinson Disease (PD), Parkinson's Disease | Recruiting | Merz Therapeutics GmbH | 120 | 2026-09-01 | 2026-10-02 | |
| A Retrospective Chart Abstraction to Investigate the Prevalence of Chronic Sialorrhea, and the Real-world Use of incobotulinumtoxinA Injections in Male and Female Participants Aged 18 Years and Older With Chronic Sialorrhea Sialorrhea | Completed | Medstar Health Research Institute | 206 | 2025-10-10 | 2026-10-19 | |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine Xeomin, Placebo - Chronic Migraine | Phase 3 | Active not recruiting | Merz Therapeutics GmbH | 808 | 2025-08-21 | 2026-10-14 |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine Xeomin, Placebo - Episodic Migraine | Phase 3 | Active not recruiting | Merz Therapeutics GmbH | 997 | 2025-08-21 | 2026-10-14 |
| A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury IncobotulinumtoxinA, Placebo - Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury | Phase 2 | Completed | Merz Therapeutics GmbH | 123 | 2023-11-22 | 2026-05-05 |
| Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool Post-stroke Spasticity | Completed | Merz Therapeutics GmbH | 70 | 2023-10-27 | 2026-05-22 | |
| Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia CC BoNT/A, CF BoNT/A, CF to CC BoNT/A - Cervical Dystonia | Completed | Merz Therapeutics GmbH | 270 | 2023-07-08 | 2024-08-21 | |
| Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss Pantovigar® vegan - Diffuse Hair Loss in Females | Not applicable | Completed | Merz Therapeutics GmbH | 39 | 2021-09-13 | 2023-07-13 |
Dystonic Disorders (1) · Fatigue (1) · Neuralgia, Postherpetic (1) · Parkinson Disease (1) · Peripheral Nerve Injuries (1) · Sialorrhea (1) · Social Stigma (1) · Torticollis (1)
Botulinum Toxins, Type A (4) · incobotulinumtoxinA (4) · Dihydroxyphenylalanine (1) · abobotulinumtoxinA (1)
Germany (5) · Austria (4) · France (3) · Poland (3) · Spain (3) · United States (3) · Canada (2) · Czechia (2) · Denmark (2) · Italy (2) · Slovakia (2) · Switzerland (2) · United Kingdom (2) · Bulgaria (1) · Hungary (1)